{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:28:03Z","timestamp":1794378483020,"version":"4.9.0"},"publisher-location":"Berlin, Heidelberg","reference-count":78,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540705789","type":"print"},{"value":"9783540705796","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-70579-6_10","type":"book-chapter","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T07:46:30Z","timestamp":1277883990000},"page":"115-125","source":"Crossref","is-referenced-by-count":3,"title":["Current Diagnosis and Future Impact of Micrometastases for Therapeutic Strategies in Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third"],"prefix":"10.1007","author":[{"given":"Asad","family":"Kutup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre F.","family":"Yekebas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob R.","family":"Izbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,18]]},"reference":[{"key":"10_CR1_10","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0360-3016(03)00782-X","volume":"57","author":"M Akamatsu","year":"2003","unstructured":"Akamatsu M, Matsumoto T, Oka K et al (2003) C-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 57:1323\u20131327","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10_CR2_10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00000658-199409000-00012","volume":"220","author":"H Akiyama","year":"1994","unstructured":"Akiyama H, Tsurumaru M, Udagawa H et al (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220(3):364\u2013372","journal-title":"Ann Surg"},{"key":"10_CR3_10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ijc.2910540209","volume":"54","author":"M al-Kasspooles","year":"1993","unstructured":"al-Kasspooles M, Moore JH, Orringer MB et al (1993) Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int J Cancer 54:213\u2013219","journal-title":"Int J Cancer"},{"key":"10_CR4_10","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2000.18.11.2201","volume":"18","author":"H Allgayer","year":"2000","unstructured":"Allgayer H, Babic R, Gruetzner KU et al (2000) c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J Clin Oncol 18:2201\u20132209","journal-title":"J Clin Oncol"},{"key":"10_CR5_10","first-page":"78","volume":"26","author":"J Baselga","year":"1999","unstructured":"Baselga J, Tripathy D, Mendelsohn J et al (1999) Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2\/neu-overexpressing metastatic breast cancer. Semin Oncol 26:78\u201383","journal-title":"Semin Oncol"},{"issue":"15","key":"10_CR6_10","first-page":"2","volume":"26","author":"WJ Blot","year":"1999","unstructured":"Blot WJ, McLaughlin JK (1999) The changing epidemiology of esophageal cancer. Semin Oncol 26(suppl 15):2\u20138","journal-title":"Semin Oncol"},{"key":"10_CR7_10","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jama.1991.03460100089030","volume":"265","author":"WJ Blot","year":"1991","unstructured":"Blot WJ, Devesa SS, Kneller RW et al (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287\u20131289","journal-title":"JAMA"},{"issue":"6","key":"10_CR8_10","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/01.sla.0000145922.25106.e3","volume":"240","author":"D Bogoevski","year":"2004","unstructured":"Bogoevski D, Yekebas EF, Schurr P et al (2004) Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement. Ann Surg 240(6):993\u20131000","journal-title":"Ann Surg"},{"issue":"4","key":"10_CR9_10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/SLA.0b013e3181656d07","volume":"247","author":"D Bogoevski","year":"2008","unstructured":"Bogoevski D, Onken F, Koenig A et al (2008) Is it time for a new TNM classification in esophageal carcinoma? Ann Surg Apr 247(4):633\u2013641","journal-title":"Ann Surg Apr"},{"key":"10_CR10_10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/ije\/29.4.645","volume":"29","author":"AA Botterweck","year":"2000","unstructured":"Botterweck AA, Schouten LJ, Volovics A et al (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29:645\u2013654","journal-title":"Int J Epidemiol"},{"key":"10_CR11_10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0046-8177(00)80195-1","volume":"31","author":"TP Brien","year":"2000","unstructured":"Brien TP, Odze RD, Sheehan CE et al (2000) HER-2\/neu gene amplification by FISH predicts poor survival in Barrett\u2019s esophagus-associated adenocarcinoma. Hum Pathol 31:35\u201339","journal-title":"Hum Pathol"},{"issue":"5","key":"10_CR12_10","first-page":"409","volume":"13","author":"J Byrne","year":"1987","unstructured":"Byrne J, Waldron R, McAvinchey D et al (1987) The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases. Eur J Surg Oncol 13(5):409\u2013411","journal-title":"Eur J Surg Oncol"},{"key":"10_CR13_10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1572-0241.1999.00776.x","volume":"94","author":"P Bytzer","year":"1999","unstructured":"Bytzer P, Christensen PB, Damkier P et al (1999) Adenocarcinoma of the esophagus and Barrett\u2019s esophagus: a population-based study. Am J Gastroenterol 94:86\u201391","journal-title":"Am J Gastroenterol"},{"key":"10_CR14_10","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/0003-4975(94)91986-0","volume":"58","author":"AG Casson","year":"1994","unstructured":"Casson AG, Rusch VW, Ginsberg RJ et al (1994) Lymph node mapping of esophageal cancer. Ann Thorac Surg 58:1569\u20131570","journal-title":"Ann Thorac Surg"},{"key":"10_CR15_10","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","volume":"83","author":"SS Devesa","year":"1998","unstructured":"Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049\u20132053","journal-title":"Cancer"},{"key":"10_CR16_10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/00000658-199506000-00007","volume":"221","author":"FG Duhaylongsod","year":"1995","unstructured":"Duhaylongsod FG, Gottfried MR, Iglehart JD et al (1995) The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus. Ann Surg 221:677\u2013683","journal-title":"Ann Surg"},{"key":"10_CR17_10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jcp.47.1.23","volume":"47","author":"JF Flejou","year":"1994","unstructured":"Flejou JF, Paraf F, Muzeau F et al (1994) Expression of c-erbB-2 oncogene product in Barrett\u2019s adenocarcinoma: pathological and prognostic correlations. J Clin Pathol 47:23\u201326","journal-title":"J Clin Pathol"},{"key":"10_CR18_10","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s002689900616","volume":"23","author":"H Friess","year":"1999","unstructured":"Friess H, Fukuda A, Tang WH et al (1999) Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3. World J Surg 23:1010\u20131018","journal-title":"World J Surg"},{"key":"10_CR19_10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1309\/KG1Y-XNGD-54NK-PP66","volume":"118","author":"H Geddert","year":"2002","unstructured":"Geddert H, Zeriouh M, Wolter M et al (2002) Gene amplification and protein overexpression of c-erb-b2 in Barrett\u2019s carcinoma and its precursor lesions. Am J Clin Pathol 118:60\u201366","journal-title":"Am J Clin Pathol"},{"key":"10_CR20_10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/jcp.48.2.129","volume":"48","author":"RH Hardwick","year":"1995","unstructured":"Hardwick RH, Shepherd NA, Moorghen M et al (1995) c-erbB-2 overexpression in the dysplasia\/carcinoma sequence of Barrett\u2019s oesophagus. J Clin Pathol 48:129\u2013132","journal-title":"J Clin Pathol"},{"key":"10_CR21_10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0748-7983(97)80139-4","volume":"23","author":"RH Hardwick","year":"1997","unstructured":"Hardwick RH, Barham CP, Ozua P et al (1997) Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis. Eur J Surg Oncol 23: 30\u201335","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10_CR22_10","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2668::AID-CNCR11>3.0.CO;2-R","volume":"86","author":"P Hermanek","year":"1999","unstructured":"Hermanek P, Hutter RV, Sobin LH et al (1999) International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 86(12):2668\u20132673","journal-title":"Cancer"},{"issue":"7","key":"10_CR23_10","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1200\/JCO.2001.19.7.1970","volume":"19","author":"SB Hosch","year":"2001","unstructured":"Hosch SB, Stoecklein NH, Pichlmeier U et al (2001) Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 19(7):1970\u20131975","journal-title":"J Clin Oncol"},{"key":"10_CR24_10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0003-4975(96)00392-X","volume":"62","author":"Y Ikeda","year":"1996","unstructured":"Ikeda Y, Ozawa S, Ando N et al (1996) Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. Ann Thorac Surg 62:835\u2013838","journal-title":"Ann Thorac Surg"},{"issue":"17","key":"10_CR25_10","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1056\/NEJM199710233371702","volume":"337","author":"JR Izbicki","year":"1997","unstructured":"Izbicki JR, Hosch SB, Pichlmeier U et al (1997) Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337(17):1188\u20131194","journal-title":"N Engl J Med"},{"key":"10_CR26_10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/gut.33.8.1033","volume":"33","author":"J Jankowski","year":"1992","unstructured":"Jankowski J, Coghill G, Hopwood D et al (1992) Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus. Gut 33:1033\u20131038","journal-title":"Gut"},{"key":"10_CR27_10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s10552-006-0037-3","volume":"17","author":"J Jeon","year":"2006","unstructured":"Jeon J, Luebeck EG, Moolgavkar SH (2006) Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States). Cancer Causes Control 17:971\u2013981","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10_CR28_10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0277-5379(87)90007-1","volume":"23","author":"M Kasper","year":"1987","unstructured":"Kasper M, Stosiek P, Typlt H et al (1987) Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues. Eur J Cancer Clin Oncol 23(2):137\u2013147","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10_CR29_10","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1023\/A:1018891923998","volume":"42","author":"R Kim","year":"1997","unstructured":"Kim R, Clarke MR, Melhem MF et al (1997) Expression of p53, PCNA, and C-erbB-2 in Barrett\u2019s metaplasia and adenocarcinoma. Dig Dis Sci 42:2453\u20132462","journal-title":"Dig Dis Sci"},{"key":"10_CR30_10","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1245\/s10434-008-0169-7","volume":"16","author":"A Koenig","year":"2009","unstructured":"Koenig A, Prenzel KL, Bogoevski D et al (2009) Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol 16:454\u2013462","journal-title":"Ann Surg Oncol"},{"key":"10_CR31_10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1023\/A:1008365216323","volume":"10","author":"C Kollmannsberger","year":"1999","unstructured":"Kollmannsberger C, Pressler H, Mayer F et al (1999) Cisplatin-refractory, HER2\/neu-expressing germ-cell cancer: induction of remission by the monoclonal antibody trastuzumab. Ann Oncol 10:1393\u20131394","journal-title":"Ann Oncol"},{"issue":"2","key":"10_CR32_10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2168.2002.01981.x","volume":"89","author":"S Komukai","year":"2002","unstructured":"Komukai S, Nishimaki T, Suzuki T et al (2002) Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma. Br J Surg 89(2):213\u2013219","journal-title":"Br J Surg"},{"key":"10_CR33_10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0748-7983(98)92403-9","volume":"24","author":"KY Lam","year":"1998","unstructured":"Lam KY, Tin L, Ma L (1998) C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions. Eur J Surg Oncol 24:431\u2013435","journal-title":"Eur J Surg Oncol"},{"key":"10_CR34_10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1200\/JCO.2004.04.105","volume":"22","author":"CJ Langer","year":"2004","unstructured":"Langer CJ, Stephenson P, Thor A et al (2004) Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on Eastern Cooperative Oncology Group Study 2598. J Clin Oncol 22:1180\u20131187","journal-title":"J Clin Oncol"},{"issue":"3","key":"10_CR35_10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/jcp.43.3.213","volume":"43","author":"U Latza","year":"1990","unstructured":"Latza U, Niedobitek G, Schwarting R et al (1990) Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 43(3):213\u2013219","journal-title":"J Clin Pathol"},{"key":"10_CR36_10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1470-2045(02)00676-9","volume":"3","author":"B Leyland-Jones","year":"2002","unstructured":"Leyland-Jones B (2002) Trastuzumab: hopes and realities. Lancet Oncol 3:137\u2013144","journal-title":"Lancet Oncol"},{"key":"10_CR37_10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.oraloncology.2004.03.002","volume":"41","author":"LD Locati","year":"2005","unstructured":"Locati LD, Rinaldi G, Bossi P et al (2005) Herceptin plus chemotherapy in relapsed and\/or metastatic salivary gland cancer. Oral Oncol 41:97\u201398","journal-title":"Oral Oncol"},{"issue":"4","key":"10_CR38_10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0039-6060(96)80138-3","volume":"119","author":"Y Maehara","year":"1996","unstructured":"Maehara Y, Oshiro T, Endo K et al (1996) Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 119(4):397\u2013402","journal-title":"Surgery"},{"key":"10_CR39_10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/sj.bjc.6602499","volume":"92","author":"K Mimura","year":"2005","unstructured":"Mimura K, Kono K, Hanawa M et al (2005) Frequencies of HER-2\/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma. Br J Cancer 92:1253\u20131260","journal-title":"Br J Cancer"},{"issue":"11","key":"10_CR40_10","first-page":"2883","volume":"47","author":"F Momburg","year":"1987","unstructured":"Momburg F, Moldenhauer G, Hammerling GJ et al (1987) Immunohistochemical study of the expression of a Mr 34, 000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 47(11):2883\u20132891","journal-title":"Cancer Res"},{"issue":"9","key":"10_CR41_10","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/1097-0142(20001101)89:9<1874::AID-CNCR2>3.3.CO;2-D","volume":"89","author":"JD Mueller","year":"2000","unstructured":"Mueller JD, Stein HJ, Oyang T et al (2000) Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer 89(9):1874\u20131882","journal-title":"Cancer"},{"key":"10_CR42_10","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/1097-0142(19940401)73:7<1785::AID-CNCR2820730703>3.0.CO;2-0","volume":"73","author":"T Nakamura","year":"1994","unstructured":"Nakamura T, Nekarda H, Hoelscher AH et al (1994) Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett\u2019s esophagus. Cancer 73:1785\u20131794","journal-title":"Cancer"},{"key":"10_CR43_10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/01.meg.0000223905.78116.38","volume":"18","author":"MA Orengo","year":"2006","unstructured":"Orengo MA, Casella C, Fontana V et al (2006) AIRT Working Group. Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986-1997. Eur J Gastroenterol Hepatol 18:739\u2013746","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10_CR44_10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrc1370","volume":"4","author":"K Pantel","year":"2004","unstructured":"Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4(6):448\u2013456","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10_CR45_10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/scd.1.1994.3.165","volume":"3","author":"K Pantel","year":"1994","unstructured":"Pantel K, Schlimok G, Angstwurm M et al (1994) Methodological analysis of immunocyto\u00adche\u00admical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3(3):165\u2013173","journal-title":"J Hematother"},{"key":"10_CR46_10","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1038\/sj.onc.1207726","volume":"23","author":"DM Parkin","year":"2004","unstructured":"Parkin DM (2004) International variation. Oncogene 23:6329\u20136340","journal-title":"Oncogene"},{"issue":"suppl 8","key":"10_CR47_10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0959-8049(01)00267-2","volume":"37","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(suppl 8):S4\u2013S66","journal-title":"Eur J Cancer"},{"issue":"9","key":"10_CR48_10","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1200\/JCO.1994.12.9.1827","volume":"12","author":"B Passlick","year":"1994","unstructured":"Passlick B, Izbicki JR, Kubuschok B et al (1994) Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol 12(9):1827\u20131832","journal-title":"J Clin Oncol"},{"key":"10_CR49_10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0165-4608(98)00036-3","volume":"106","author":"DL Persons","year":"1998","unstructured":"Persons DL, Croughan WS, Borelli KA et al (1998) Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions. Cancer Genet Cytogenet 106:11\u201317","journal-title":"Cancer Genet Cytogenet"},{"key":"10_CR50_10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s10434-999-0290-2","volume":"6","author":"W Polkowski","year":"1999","unstructured":"Polkowski W, van Sandick JW, Offerhaus GJ et al (1999) Prognostic value of Lauren classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 6:290\u2013297","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10_CR51_10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1245\/s10434-006-9141-6","volume":"14","author":"KL Prenzel","year":"2007","unstructured":"Prenzel KL, Koenig A, Schneider PM et al (2007) Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer. Ann Surg Oncol 14(2):954\u2013959","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10_CR52_10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/00313028909059522","volume":"21","author":"WA Raymond","year":"1989","unstructured":"Raymond WA, Leong AS (1989) Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer. Pathology; 21(1):11\u20135","journal-title":"Pathology"},{"key":"10_CR53_10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1081\/CNV-100103852","volume":"19","author":"JS Ross","year":"2001","unstructured":"Ross JS, McKenna BJ (2001) The HER-2\/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 19:554\u2013568","journal-title":"Cancer Invest"},{"key":"10_CR54_10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00000421-200110000-00016","volume":"24","author":"H Safran","year":"2001","unstructured":"Safran H, Steinhoff M, Mangray S et al (2001) Overexpression of the HER-2\/neu oncogene in pancreatic adenocarcinoma. Am J Clin Oncol 24:496\u2013499","journal-title":"Am J Clin Oncol"},{"key":"10_CR55_10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1081\/CNV-200032951","volume":"22","author":"H Safran","year":"2004","unstructured":"Safran H, DiPetrillo T, Nadeem A et al (2004) Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study. Cancer Invest 22:670\u2013677","journal-title":"Cancer Invest"},{"issue":"2","key":"10_CR56_10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ijrobp.2006.08.076","volume":"67","author":"H Safran","year":"2007","unstructured":"Safran H, DiPetrillo T, Akerman P et al (2007) Phase I\/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma. Int J Radiat Oncol Biol Phys 67(2):405\u2013409","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10_CR57_10","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.2004.10.184","volume":"22","author":"T Sano","year":"2004","unstructured":"Sano T, Sasako M, Yamamoto S et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767\u20132773","journal-title":"J Clin Oncol"},{"key":"10_CR58_10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0304-3835(93)90205-N","volume":"75","author":"ER Sauter","year":"1993","unstructured":"Sauter ER, Keller SM, Erner S et al (1993) HER-2\/neu: a differentiation marker in adenocarcinoma of the esophagus. Cancer Lett 75:41\u201344","journal-title":"Cancer Lett"},{"issue":"4","key":"10_CR59_10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/jso.20582","volume":"94","author":"PG Schurr","year":"2006","unstructured":"Schurr PG, Yekebas EF, Kaifi JT et al (2006) Lymphatic spread and microinvolvement in \u00adadenocarcinoma of the esophago-gastric junction. J Surg Oncol 94(4):307\u2013315","journal-title":"J Surg Oncol"},{"key":"10_CR60_10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","volume":"85","author":"JR Siewert","year":"1998","unstructured":"Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457\u20131459","journal-title":"Br J Surg"},{"key":"10_CR61_10","first-page":"25","volume":"58","author":"JR Siewert","year":"1987","unstructured":"Siewert JR, Holscher AH, Becker K et al (1987) Cardia cancer: attempt at a therapeutically relevant classification. Chirurg 58:25\u201332","journal-title":"Chirurg"},{"issue":"8","key":"10_CR62_10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/bjs.1800830836","volume":"83","author":"JR Siewert","year":"1996","unstructured":"Siewert JR, Kestlmeier R, Busch R et al (1996) Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 83(8):1144\u20131147","journal-title":"Br J Surg"},{"key":"10_CR63_10","first-page":"2025","volume":"12","author":"Z Suo","year":"1992","unstructured":"Suo Z, Holm R, Nesland JM (1992) Squamous cell carcinomas, an immunohistochemical and ultrastructural study. Anticancer Res 12:2025\u20132031","journal-title":"Anticancer Res"},{"key":"10_CR64_10","first-page":"2797","volume":"15","author":"Z Suo","year":"1995","unstructured":"Suo Z, Su W, Holm R et al (1995) Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas. Anticancer Res 15:2797\u20132798","journal-title":"Anticancer Res"},{"key":"10_CR65_10","first-page":"119","volume":"11","author":"P Suwanagool","year":"1993","unstructured":"Suwanagool P, Parichatikanond P, Maeda S (1993) Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study. Asian Pac J Allergy Immunol 11:119\u2013122","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10_CR66_10","first-page":"28","volume":"57","author":"S Tanaka","year":"1997","unstructured":"Tanaka S, Mori M, Akiyoshi T et al (1997) Coexpression of Grb7 with epidermal growth factor receptor or Her2\/erbB2 in human advanced esophageal carcinoma. Cancer Res 57:28\u201331","journal-title":"Cancer Res"},{"key":"10_CR67_10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1200\/JCO.2004.06.557","volume":"22","author":"D Tripathy","year":"2004","unstructured":"Tripathy D, Slamon DJ, Cobleigh M et al (2004) Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression. J Clin Oncol 22:1063\u20131070","journal-title":"J Clin Oncol"},{"issue":"6","key":"10_CR68_10","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/ijc.23691","volume":"123","author":"KF Trivers","year":"2008","unstructured":"Trivers KF, Sabatino SA, Stewart SL (2008) Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer 123(6):1422\u20131428","journal-title":"Int J Cancer"},{"key":"10_CR69_10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/mp.56.6.313","volume":"56","author":"NJ Trudgill","year":"2003","unstructured":"Trudgill NJ, Suvarna SK, Royds JA et al (2003) Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction. Mol Pathol 56:313\u2013317","journal-title":"Mol Pathol"},{"key":"10_CR70_10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/jnci\/97.12.870","volume":"97","author":"RS Tuma","year":"2005","unstructured":"Tuma RS (2005) Trastuzumab trials steal show at ASCO meeting. J Natl Cancer Inst 97:870\u2013871","journal-title":"J Natl Cancer Inst"},{"key":"10_CR71_10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ijc.10427","volume":"99","author":"AP Vizcaino","year":"2002","unstructured":"Vizcaino AP, Moreno V, Lambert R et al (2002) Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973\u20131995. Int J Cancer 99:860\u2013868","journal-title":"Int J Cancer"},{"key":"10_CR72_10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1155\/2000\/947249","volume":"20","author":"A Walch","year":"2000","unstructured":"Walch A, Bink K, Gais P et al (2000a) Evaluation of c-erbB-2 overexpression and Her-2\/neu gene copy number heterogeneity in Barrett\u2019s adenocarcinoma. Anal Cell Pathol 20:25\u201332","journal-title":"Anal Cell Pathol"},{"key":"10_CR73_10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/modpathol.3880143","volume":"13","author":"AK Walch","year":"2000","unstructured":"Walch AK, Zitzelsberger HF, Bink K et al (2000b) Molecular genetic changes in metastatic primary Barrett\u2019s adenocarcinoma and related lymph node metastases: comparison with nonmetastatic Barrett\u2019s adenocarcinoma. Mod Pathol 13:814\u2013824","journal-title":"Mod Pathol"},{"key":"10_CR74_10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/labinvest.3780289","volume":"81","author":"A Walch","year":"2001","unstructured":"Walch A, Specht K, Bink K et al (2001) Her-2\/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett\u2019s esophagus. Lab Invest 81:791\u2013801","journal-title":"Lab Invest"},{"key":"10_CR75_10","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1080\/11024150152707725","volume":"167","author":"C Walther","year":"2001","unstructured":"Walther C, Zilling T, Perfekt R et al (2001) Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997. Eur J Surg 167:748\u2013757","journal-title":"Eur J Surg"},{"issue":"4","key":"10_CR76_10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.athoracsur.2004.04.045","volume":"78","author":"TA Waterman","year":"2004","unstructured":"Waterman TA, Hagen JA, Peters JH et al (2004) The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg 78(4):1161\u20131169","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10_CR77_10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1067\/msy.2001.113819","volume":"129","author":"K Z\u2019Graggen","year":"2001","unstructured":"Z\u2019Graggen K, Centeno BA, Fernandez-del Castillo C et al (2001) Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. Surgery 129(5):537\u2013546","journal-title":"Surgery"},{"key":"10_CR78_10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/hupa.2003.60","volume":"34","author":"D Zhang","year":"2003","unstructured":"Zhang D, Salto-Tellez M, Do E et al (2003) Evaluation of HER-2\/neu oncogene status in breast tumors on tissue microarrays. Hum Pathol 34:362\u2013368","journal-title":"Hum Pathol"}],"container-title":["Recent Results in Cancer Research","Adenocarcinoma of the Esophagogastric Junction"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-70579-6_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T07:11:10Z","timestamp":1635577870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-70579-6_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540705789","9783540705796"],"references-count":78,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-70579-6_10","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-540-70579-6","asserted-by":"object"}]},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}